Investigation into the immunological effects of miltefosine, a new anticancer agent under development View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1991-09

AUTHORS

P. Hilgard, E. Kampherm, L. Nolan, J. Pohl, T. Reissmann

ABSTRACT

Miltefosine is the prototype of alkylphosphocholines, a new class of anticancer agents related to alkyl-lysophospholipids. These agents were considered to possess potent immunomodulatory properties. Miltefosine was highly active against the human KB tumour xenograft in nude mice, leading to growth inhibition as well as regression of large established tumours, which suggested that its mode of action was not mediated by the T cell system. In vivo natural killer cell activity was measured by chromium release of YAC-1 cells using spleen cells from treated animals as effector cells. Miltefosine had no significant effect on YAC-1 cytolysis. Similarly, the compound did not induce cytotoxic spleen cells against KB target cells. The results were identical when spleen cells from tumour-bearing animals were used. Humoral antibody production in rats following sheep red blood cell immunization was not changed by miltefosine pretreatment. Finally, the in vitro phagocytic activity of mouse bone marrow macrophages was not stimulated but rather inhibited in a dose-dependent manner. In conclusion, there is no experimental evidence that the miltefosine action is mediated by the host immune system and no major immunotoxicity was observed. More... »

PAGES

403-408

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf01612758

DOI

http://dx.doi.org/10.1007/bf01612758

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027286828

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1890137


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibody Formation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity, Cellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrophages", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phagocytosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylcholine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spleen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgard", 
        "givenName": "P.", 
        "id": "sg:person.01023655171.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kampherm", 
        "givenName": "E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nolan", 
        "givenName": "L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pohl", 
        "givenName": "J.", 
        "id": "sg:person.0750105001.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reissmann", 
        "givenName": "T.", 
        "id": "sg:person.01340535776.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00391352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001265313", 
          "https://doi.org/10.1007/bf00391352"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00391352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001265313", 
          "https://doi.org/10.1007/bf00391352"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(85)90416-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003268028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(85)90416-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003268028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02535547", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026546527", 
          "https://doi.org/10.1007/bf02535547"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(88)90336-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033699947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0305-7372(85)90036-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033865428"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/znb-1964-1207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040413145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/znb-1964-1207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040413145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02535540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044328242", 
          "https://doi.org/10.1007/bf02535540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/72.1.53", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1081838333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082121534", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1991-09", 
    "datePublishedReg": "1991-09-01", 
    "description": "Miltefosine is the prototype of alkylphosphocholines, a new class of anticancer agents related to alkyl-lysophospholipids. These agents were considered to possess potent immunomodulatory properties. Miltefosine was highly active against the human KB tumour xenograft in nude mice, leading to growth inhibition as well as regression of large established tumours, which suggested that its mode of action was not mediated by the T cell system. In vivo natural killer cell activity was measured by chromium release of YAC-1 cells using spleen cells from treated animals as effector cells. Miltefosine had no significant effect on YAC-1 cytolysis. Similarly, the compound did not induce cytotoxic spleen cells against KB target cells. The results were identical when spleen cells from tumour-bearing animals were used. Humoral antibody production in rats following sheep red blood cell immunization was not changed by miltefosine pretreatment. Finally, the in vitro phagocytic activity of mouse bone marrow macrophages was not stimulated but rather inhibited in a dose-dependent manner. In conclusion, there is no experimental evidence that the miltefosine action is mediated by the host immune system and no major immunotoxicity was observed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf01612758", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "117"
      }
    ], 
    "name": "Investigation into the immunological effects of miltefosine, a new anticancer agent under development", 
    "pagination": "403-408", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "81fc4881d2084cf12f48c0810d685fc76e5d54d0cffba72a237046a749294221"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1890137"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf01612758"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027286828"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf01612758", 
      "https://app.dimensions.ai/details/publication/pub.1027286828"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000370_0000000370/records_46777_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF01612758"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'


 

This table displays all metadata directly associated to this object as RDF triples.

203 TRIPLES      21 PREDICATES      56 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf01612758 schema:about N0750ae8e646a434aa3f53a685deff1a8
2 N0a833b34b36d42c987b2ee72a8b8f033
3 N19bceafff6c648d0b5f356ede9e22eae
4 N59f68315e6854a699e72119b564bdb39
5 N74bbe80a8c9441c693b7362ea95d7012
6 N76d34cfe990a43c083fe7d1439352529
7 N897c3b5762cb492faf9f5253037dc877
8 N8ae579b78229496ea5aa9e0e980a0085
9 N8eb1f44a3c6c4ef5989a3f861947bd7e
10 N9ed990b8b2dd4bc9b3989b431c45d785
11 Na94ddfb07679415ba5598821af2fe953
12 Nab1f33be5a634c52889f9bc2b42bed03
13 Nb78c189d2e7c4c3db8aa4676876e0906
14 Nc563161c0eb64125a70108c255f7da39
15 Nc78a8599825a4028840dbbe5ddaa7ce1
16 Ndf4a308f2c8c43dbb9f94680d9a7cc43
17 Nee30f7c7a898438c9d9cb36dc0396b33
18 Nfe1198485e604fd787e866e499b374ed
19 anzsrc-for:11
20 anzsrc-for:1107
21 schema:author Ne950cd98673646b7aa71c578e286fc77
22 schema:citation sg:pub.10.1007/bf00391352
23 sg:pub.10.1007/bf02535540
24 sg:pub.10.1007/bf02535547
25 https://app.dimensions.ai/details/publication/pub.1082121534
26 https://doi.org/10.1016/0022-1759(85)90416-8
27 https://doi.org/10.1016/0277-5379(88)90336-7
28 https://doi.org/10.1016/0305-7372(85)90036-2
29 https://doi.org/10.1093/jnci/72.1.53
30 https://doi.org/10.1515/znb-1964-1207
31 schema:datePublished 1991-09
32 schema:datePublishedReg 1991-09-01
33 schema:description Miltefosine is the prototype of alkylphosphocholines, a new class of anticancer agents related to alkyl-lysophospholipids. These agents were considered to possess potent immunomodulatory properties. Miltefosine was highly active against the human KB tumour xenograft in nude mice, leading to growth inhibition as well as regression of large established tumours, which suggested that its mode of action was not mediated by the T cell system. In vivo natural killer cell activity was measured by chromium release of YAC-1 cells using spleen cells from treated animals as effector cells. Miltefosine had no significant effect on YAC-1 cytolysis. Similarly, the compound did not induce cytotoxic spleen cells against KB target cells. The results were identical when spleen cells from tumour-bearing animals were used. Humoral antibody production in rats following sheep red blood cell immunization was not changed by miltefosine pretreatment. Finally, the in vitro phagocytic activity of mouse bone marrow macrophages was not stimulated but rather inhibited in a dose-dependent manner. In conclusion, there is no experimental evidence that the miltefosine action is mediated by the host immune system and no major immunotoxicity was observed.
34 schema:genre research_article
35 schema:inLanguage en
36 schema:isAccessibleForFree false
37 schema:isPartOf N170ca94c531b47afa7ac278891843c40
38 Nad448ef6ac4d44e487dd2c65ccb179fd
39 sg:journal.1313647
40 schema:name Investigation into the immunological effects of miltefosine, a new anticancer agent under development
41 schema:pagination 403-408
42 schema:productId N2b904fbb65124b34a24197be11640dd5
43 N314c18b3e1e748d8a57154d1c93d6d32
44 N628fcb2d274f465a8c5527c23609cf90
45 Na31c09f3238d4035880cdd270ce06d8f
46 Naf5fc1314dea4b7598962e1a751144d6
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027286828
48 https://doi.org/10.1007/bf01612758
49 schema:sdDatePublished 2019-04-11T13:36
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N74ae70b6b485494ba18c7c3cdc486398
52 schema:url http://link.springer.com/10.1007/BF01612758
53 sgo:license sg:explorer/license/
54 sgo:sdDataset articles
55 rdf:type schema:ScholarlyArticle
56 N0750ae8e646a434aa3f53a685deff1a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Humans
58 rdf:type schema:DefinedTerm
59 N0a833b34b36d42c987b2ee72a8b8f033 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Animals
61 rdf:type schema:DefinedTerm
62 N170ca94c531b47afa7ac278891843c40 schema:issueNumber 5
63 rdf:type schema:PublicationIssue
64 N19bceafff6c648d0b5f356ede9e22eae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Male
66 rdf:type schema:DefinedTerm
67 N2b904fbb65124b34a24197be11640dd5 schema:name dimensions_id
68 schema:value pub.1027286828
69 rdf:type schema:PropertyValue
70 N314c18b3e1e748d8a57154d1c93d6d32 schema:name nlm_unique_id
71 schema:value 7902060
72 rdf:type schema:PropertyValue
73 N3a1bf8c5e4d24dedb11c8dc053d6e7f8 schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
74 rdf:type schema:Organization
75 N3a9de2836f3245ee8cee87818aff637f rdf:first sg:person.01340535776.53
76 rdf:rest rdf:nil
77 N4c09f8cc90ea4fd8915da41a457d9d70 schema:affiliation Ne2a951b68cb348668feb845d55cc6ac5
78 schema:familyName Kampherm
79 schema:givenName E.
80 rdf:type schema:Person
81 N512a0e014e5c451d91e6c79289c524fe schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
82 rdf:type schema:Organization
83 N59f68315e6854a699e72119b564bdb39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Antibody Formation
85 rdf:type schema:DefinedTerm
86 N628fcb2d274f465a8c5527c23609cf90 schema:name doi
87 schema:value 10.1007/bf01612758
88 rdf:type schema:PropertyValue
89 N6297b2f6ee8841c7bafe3627252a38bf rdf:first sg:person.0750105001.98
90 rdf:rest N3a9de2836f3245ee8cee87818aff637f
91 N7080591568f3490a97c3ba2b20f905ba rdf:first Na364cd82bab64eafb1f87b96c7a67ee2
92 rdf:rest N6297b2f6ee8841c7bafe3627252a38bf
93 N74ae70b6b485494ba18c7c3cdc486398 schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N74bbe80a8c9441c693b7362ea95d7012 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Rats, Inbred Strains
97 rdf:type schema:DefinedTerm
98 N76d34cfe990a43c083fe7d1439352529 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Spleen
100 rdf:type schema:DefinedTerm
101 N7aa2f8adfa6d4ff7bb12972de16464f5 rdf:first N4c09f8cc90ea4fd8915da41a457d9d70
102 rdf:rest N7080591568f3490a97c3ba2b20f905ba
103 N897c3b5762cb492faf9f5253037dc877 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Female
105 rdf:type schema:DefinedTerm
106 N8ae579b78229496ea5aa9e0e980a0085 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Immunity, Cellular
108 rdf:type schema:DefinedTerm
109 N8eb1f44a3c6c4ef5989a3f861947bd7e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Antineoplastic Agents
111 rdf:type schema:DefinedTerm
112 N9ed990b8b2dd4bc9b3989b431c45d785 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Mice
114 rdf:type schema:DefinedTerm
115 Na31c09f3238d4035880cdd270ce06d8f schema:name pubmed_id
116 schema:value 1890137
117 rdf:type schema:PropertyValue
118 Na364cd82bab64eafb1f87b96c7a67ee2 schema:affiliation N3a1bf8c5e4d24dedb11c8dc053d6e7f8
119 schema:familyName Nolan
120 schema:givenName L.
121 rdf:type schema:Person
122 Na94ddfb07679415ba5598821af2fe953 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Carcinoma, Squamous Cell
124 rdf:type schema:DefinedTerm
125 Nab1f33be5a634c52889f9bc2b42bed03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Neoplasm Transplantation
127 rdf:type schema:DefinedTerm
128 Nad448ef6ac4d44e487dd2c65ccb179fd schema:volumeNumber 117
129 rdf:type schema:PublicationVolume
130 Naf5fc1314dea4b7598962e1a751144d6 schema:name readcube_id
131 schema:value 81fc4881d2084cf12f48c0810d685fc76e5d54d0cffba72a237046a749294221
132 rdf:type schema:PropertyValue
133 Nb78c189d2e7c4c3db8aa4676876e0906 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Phagocytosis
135 rdf:type schema:DefinedTerm
136 Nc563161c0eb64125a70108c255f7da39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Neoplasms, Experimental
138 rdf:type schema:DefinedTerm
139 Nc78a8599825a4028840dbbe5ddaa7ce1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Macrophages
141 rdf:type schema:DefinedTerm
142 Ndf4a308f2c8c43dbb9f94680d9a7cc43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Rats
144 rdf:type schema:DefinedTerm
145 Ne2a951b68cb348668feb845d55cc6ac5 schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
146 rdf:type schema:Organization
147 Ne950cd98673646b7aa71c578e286fc77 rdf:first sg:person.01023655171.21
148 rdf:rest N7aa2f8adfa6d4ff7bb12972de16464f5
149 Nee30f7c7a898438c9d9cb36dc0396b33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Tumor Cells, Cultured
151 rdf:type schema:DefinedTerm
152 Nef8829d44fb3446b8ca92c146416ce9a schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
153 rdf:type schema:Organization
154 Nf43088434d2242408d0e71fc26fcc0e6 schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
155 rdf:type schema:Organization
156 Nfe1198485e604fd787e866e499b374ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Phosphorylcholine
158 rdf:type schema:DefinedTerm
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
163 schema:name Immunology
164 rdf:type schema:DefinedTerm
165 sg:journal.1313647 schema:issn 0171-5216
166 1432-1335
167 schema:name Journal of Cancer Research and Clinical Oncology
168 rdf:type schema:Periodical
169 sg:person.01023655171.21 schema:affiliation Nf43088434d2242408d0e71fc26fcc0e6
170 schema:familyName Hilgard
171 schema:givenName P.
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21
173 rdf:type schema:Person
174 sg:person.01340535776.53 schema:affiliation Nef8829d44fb3446b8ca92c146416ce9a
175 schema:familyName Reissmann
176 schema:givenName T.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53
178 rdf:type schema:Person
179 sg:person.0750105001.98 schema:affiliation N512a0e014e5c451d91e6c79289c524fe
180 schema:familyName Pohl
181 schema:givenName J.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98
183 rdf:type schema:Person
184 sg:pub.10.1007/bf00391352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001265313
185 https://doi.org/10.1007/bf00391352
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/bf02535540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044328242
188 https://doi.org/10.1007/bf02535540
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/bf02535547 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026546527
191 https://doi.org/10.1007/bf02535547
192 rdf:type schema:CreativeWork
193 https://app.dimensions.ai/details/publication/pub.1082121534 schema:CreativeWork
194 https://doi.org/10.1016/0022-1759(85)90416-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003268028
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/0277-5379(88)90336-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033699947
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/0305-7372(85)90036-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033865428
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1093/jnci/72.1.53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1081838333
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1515/znb-1964-1207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040413145
203 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...